Advances on Molecular Mechanism and Clinical Treatment in Invasive Mucinous Adenocarcinoma
Invasive mucinous adenocarcinoma (IMA) is a special type of lung adenocarcinoma that accounts for 2% to 10% of all lung adenocarcinoma. Surgical treatment is preferred for IMA, and traditional chemotherapy drugs and targeted therapy drugs have poor efficacy in this disease. IMA has unique prognostic...
Saved in:
| Main Authors: | Minjun SHI, Bo YE |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2024-09-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application and progress of non-invasive imaging in predicting lung invasive non-mucinous adenocarcinoma under the new IASLC grading guidelines
by: Jinbao Feng, et al.
Published: (2025-01-01) -
Pulmonary Mucinous Adenocarcinoma
by: A. Yu. Usacheva, et al.
Published: (2021-03-01) -
A unique case of pulmonary minimally invasive mucinous adenocarcinoma arising from atypical goblet cell hyperplasia in the bronchial epithelium of a 9-year-old girl
by: Ping Zhou, et al.
Published: (2025-04-01) -
Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy
by: Micah Tratt, BA, et al.
Published: (2025-07-01) -
Mucinous rectal adenocarcinoma recurrence: A case report and literature review
by: Riya Sood, BS, et al.
Published: (2025-04-01)